NEW YORK (GenomeWeb) – HTG Molecular today went public in the US, offering 3,570,000 shares of common stock at an initial public offering price of $14 per share.

The Tucson, Arizona-based molecular diagnostics firm expects to raise net proceeds of approximately $44.4 million, which could rise to $51.4 million if the underwriters exercise their overallotment option of 535,500 shares within 30 days of the offering. Canaccord Genuity, Leerink Partners, and JMP Securities are the underwriters on the offering.